Episodios

  • Curable HPV Positive Head and Neck Cancer

    Curable HPV Positive Head and Neck Cancer
    Jul 30 2024
    Drs. Patel, Sheth, and Weiss discuss current treatment options and emerging data in curable HPV positive head and neck cancer.
    Más Menos
    12 m
  • What is a Bone Marrow Transplant?

    What is a Bone Marrow Transplant?
    Jun 12 2024
    Dr. Marco Ruiz explains the concept of bone marrow transplant, and how it is used in treating blood cancers.
    Más Menos
    8 m
  • Q&A: Do People in Rural Communities Have Equal Access to Treatment Options?

    Q&A: Do People in Rural Communities Have Equal Access to Treatment Options?
    Jun 10 2024
    Drs. Goodman, Phillips, Taneja, and Rajeeve discuss whether a patient's location can affect the treatments they can access and their overall prognosis.
    Más Menos
    4 m
  • Q&A: Is my Clinical Trial Affecting my Body's Reaction to the Covid-19 Vaccine?

    Q&A: Is my Clinical Trial Affecting my Body's Reaction to the Covid-19 Vaccine?
    Jun 5 2024
    Drs. Goodman, Phillips, Taneja, and Rajeeve discuss how to navigate treatment and Covid vaccination.
    Más Menos
    4 m
  • Bispecific Antibodies in Myeloma: Approvals and Clinical Trials

    Bispecific Antibodies in Myeloma: Approvals and Clinical Trials
    May 31 2024
    Dr. Sridevi Rajeeve discusses current FDA approved bispecific antibodies and ones coming from clinical trials.
    Más Menos
    4 m
  • Curative Strategies for Patients with Smoldering Multiple Myeloma

    Curative Strategies for Patients with Smoldering Multiple Myeloma
    May 23 2024
    Dr. Alankrita Taneja examines data from the CESAR trial, and discusses curative strategies for Smoldering Multiple Myeloma.
    Más Menos
    3 m
  • Management of Bispecific Antibodies Side Effects

    Management of Bispecific Antibodies Side Effects
    May 17 2024
    Dr. Sridevi Rajeeve discusses possible side effects from bispecific antibodies, and how to manage them.
    Más Menos
    3 m
  • Teclistamab, Talquetamab, and Elranatamab: Response Rates and Data

    Teclistamab, Talquetamab, and Elranatamab: Response Rates and Data
    May 10 2024
    Dr. Sridevi Rajeeve discusses the unprecedented response rates in patients treated with teclistamab, talquetamab, and elranatamab, as well as their clinical trial data.
    Más Menos
    6 m